These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7658564)

  • 1. Resolution of metastatic bone lesions following combination therapy with active vitamin D3 analogue and interferon-alpha in a patient with renal cell carcinoma.
    Fujioka T; Okamoto T; Suzuki Y; Aoki H; Numasato S; Kubo T
    J Urol; 1995 Oct; 154(4):1475-6. PubMed ID: 7658564
    [No Abstract]   [Full Text] [Related]  

  • 2. Metastatic renal cell carcinoma to the hyoid bone.
    Lee HS; Lee JH; Kim SW; Lee KD
    Otolaryngol Head Neck Surg; 2010 Jun; 142(6):913-4. PubMed ID: 20493369
    [No Abstract]   [Full Text] [Related]  

  • 3. Regression of pulmonary and multiple skeletal metastases from renal cell carcinoma by nephrectomy and alpha-interferon therapy: a case report.
    Ibayashi K; Ando M; Gotoh E
    Jpn J Clin Oncol; 1993 Dec; 23(6):378-83. PubMed ID: 8283792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of posttherapeutic sclerotic change of bone metastasis from renal cell carcinoma which proved histopathologically to be complete response.
    Shimizu TS; Uchida T; Shibata Y; Satoh J; Sugihara S; Maehara Y
    Urol Int; 1994; 53(3):172-5. PubMed ID: 7645148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic renal-cell carcinoma: what causes occasional dramatic regressions?
    Young RC
    N Engl J Med; 1998 Apr; 338(18):1305-6. PubMed ID: 9562587
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adjuvant therapy with vinblastine and interferon in metastatic renal carcinoma].
    Cocimano V; Marino G; Brigato R; Cevoli R; Griffa D
    Minerva Urol Nefrol; 1989; 41(3):187-9. PubMed ID: 2617374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of renal carcinoma with distant metastases].
    Fosså SD; Aass N; Tveter K; Dahl O
    Tidsskr Nor Laegeforen; 2000 Aug; 120(19):2274-8. PubMed ID: 10997087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous subcutaneous injection therapy with interferon-alpha for renal cell carcinoma patients with bone metastasis].
    Maruoka M; Nishikawa Y; Miyauchi T; Nagayama T
    Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1488-92. PubMed ID: 7474639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible synergy of radiotherapy and chemo-immunotherapy in metastatic renal cell carcinoma (RCC).
    Brinkmann OA; Bruns F; Prott FJ; Hertle L
    Anticancer Res; 1999; 19(2C):1583-7. PubMed ID: 10365150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie.
    Negrier S; Escudier B; Lasset C; Douillard JY; Savary J; Chevreau C; Ravaud A; Mercatello A; Peny J; Mousseau M; Philip T; Tursz T
    N Engl J Med; 1998 Apr; 338(18):1272-8. PubMed ID: 9562581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of complete resolution of multiple metastases of advanced renal cell carcinoma following partial jejunotomy in intestinal metastases and interferon therapy].
    Miyata M; Watabe Y; Okamura K; Fujisawa M; Arima S; Yachiku S
    Hinyokika Kiyo; 1988 Oct; 34(10):1783-8. PubMed ID: 3245527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemotherapy for metastatic renal cell carcinoma using a regimen of interleukin-2, interferon-alpha and 5-fluorouracil.
    Hofmockel G; Langer W; Theiss M; Gruss A; Frohmüller HG
    J Urol; 1996 Jul; 156(1):18-21. PubMed ID: 8648791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of combined treatment with interferon-alpha and active vitamin D3 for Japanese patients with metastatic renal cell carcinoma.
    Obara W; Mizutani Y; Oyama C; Akaza H; Ishii N; Kohri K; Namiki M; Okuyama A; Shima H; Yokoyama M; Shuin T; Miki T; Watanabe Y; Fujioka T
    Int J Urol; 2008 Sep; 15(9):794-9. PubMed ID: 18651865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant interferon alfa on bone metastases of renal-cell carcinoma.
    Fosså SD; Lien HH; Lindegaard M
    N Engl J Med; 1991 Feb; 324(9):633-4. PubMed ID: 1992326
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of metastatic spinal tumor from renal cancer reduced by interferon-alpha].
    Suzuki T; Tokuno H; Hayashi H; Egashira M; Kiyama M; Kubota K; Hirayama A; Hakuba A
    No Shinkei Geka; 1993 Nov; 21(11):1049-53. PubMed ID: 8255382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma.
    Kriegmair M; Oberneder R; Hofstetter A
    Urology; 1995 May; 45(5):758-62. PubMed ID: 7747370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival following multidisciplinary treatment of metastatic sarcomatoid renal cell carcinoma: a case report.
    Yaegashi H; Izumi K; Konaka H; Mizokami A; Namiki M
    J Med Case Rep; 2015 Nov; 9():261. PubMed ID: 26582158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete regression of skeletal metastases from hypernephroma after angioinfarction and medroxyprogesterone acetate therapy.
    Amin R
    Urology; 1988 Sep; 32(3):254-8. PubMed ID: 2970709
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term interferon treatment in metastatic renal cell carcinoma.
    Levens W; Rübben H; Ingenhag W
    Eur Urol; 1989; 16(5):378-81. PubMed ID: 2776808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients.
    Lopez Hänninen E; Kirchner H; Atzpodien J
    J Urol; 1996 Jan; 155(1):19-25. PubMed ID: 7490829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.